Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis

作者: Marcos Vinicius Perini , Andre Luis Montagnini , Renata Coudry , Rosely Patzina , Sonia Penteado

DOI: 10.1111/ANS.12399

关键词:

摘要: Background Identification of molecular markers in pancreatic adenocarcinoma (PA) has the potential to guide targeted therapy. The objective this study is determine prognostic significance epidermal growth factor receptor (EGFR) expression (membrane and cytoplasmic) resected PA its correlation with lymph node metastasis survival. Methods EGFR overexpression was determined by immunohistochemistry, pattern compared between primary tumour, adjacent normal pancreas involved nodes. Results A total 88 patients had curative resection. No difference found mEGFR tumoural metastatic nodal tissues (P = 0.28). Median overall survival time 22.9 months. Overall cumulative 1-, 3- 5-year 48%, 20% 18%, respectively. In positive tumour expression, 46% at 1 year, 8% 3 years 0% 5 < 0.05). Univariate analysis showed that male gender, portal vein (PV) resection, perineural, lymphovascular peri-pancreatic invasion, margins tissue worse survival. Multivariate PV vascular perineural invasion remained independent predictors poor survival. Conclusion Positive associated decreased survival; however, it not an factor.

参考文章(25)
Elan R. Witkowski, Jillian K. Smith, Jennifer F. Tseng, Outcomes following resection of pancreatic cancer. Journal of Surgical Oncology. ,vol. 107, pp. 97- 103 ,(2013) , 10.1002/JSO.23267
Philip Q. Bao, Ramesh K. Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh, Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer. Annals of Surgical Oncology. ,vol. 18, pp. 1122- 1129 ,(2011) , 10.1245/S10434-010-1401-9
S Boeck, A Jung, R P Laubender, J Neumann, R Egg, C Goritschan, U Vehling-Kaiser, C Winkelmann, L Fischer von Weikersthal, M R Clemens, T C Gauler, A Märten, S Klein, G Kojouharoff, M Barner, M Geissler, T F Greten, U Mansmann, T Kirchner, V Heinemann, EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. British Journal of Cancer. ,vol. 108, pp. 469- 476 ,(2013) , 10.1038/BJC.2012.495
TAKAHIRO EINAMA, SHIGETO UEDA, HITOSHI TSUDA, KAZUHIRO OGASAWARA, KAZUO HATSUSE, OSAMU MATSUBARA, SATORU TODO, JUNJI YAMAMOTO, Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma Experimental and Therapeutic Medicine. ,vol. 3, pp. 931- 936 ,(2012) , 10.3892/ETM.2012.518
Yanhong Deng, Brenda F Kurland, Jianping Wang, Jiong Bi, Wen Li, Sujata Rao, Ping Lan, Tongyu Lin, Edward Lin, None, High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. American Journal of Clinical Oncology. ,vol. 32, pp. 245- 252 ,(2009) , 10.1097/COC.0B013E3181891326
Kosuke Tobita, Hiroshi Kijima, Shoichi Dowaki, Hiroyuki Kashiwagi, Yasuo Ohtani, Yasuhisa Oida, Hitoshi Yamazaki, Masato Nakamura, Yoshito Ueyama, Makiko Tanaka, Sadaki Inokuchi, Hiroyasu Makuuchi, Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis International Journal of Molecular Medicine. ,vol. 11, pp. 305- 309 ,(2003) , 10.3892/IJMM.11.3.305
David Liu, Julio A.Aguirre Ghiso, Yeriel Estrada, Liliana Ossowski, EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma Cancer Cell. ,vol. 1, pp. 445- 457 ,(2002) , 10.1016/S1535-6108(02)00072-7
Amit Mahipal, Mary J. Mcdonald, Agnieszka Witkiewicz, Brian I. Carr, Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma Medical Oncology. ,vol. 29, pp. 134- 139 ,(2012) , 10.1007/S12032-010-9802-Y
Yoichiro Yamanaka, Helmut Friess, Michael S. Kobrin, Markus Büchler, Jürgen Kunz, Hans G. Beger, Murray Korc, Overexpression of HER2/neu oncogene in human pancreatic carcinoma Human Pathology. ,vol. 24, pp. 1127- 1134 ,(1993) , 10.1016/0046-8177(93)90194-L
H.G. Smeenk, J. Erdmann, H. van Dekken, R. van Marion, W.C.J. Hop, J. Jeekel, C.H.J. van Eijck, Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R. Digestive Surgery. ,vol. 24, pp. 38- 45 ,(2007) , 10.1159/000100917